No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs12500853 |
chr4:8357923-8357924 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs556412756 |
chr4:8357954-8357955 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs139738876 |
chr4:8357955-8357956 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs60387429 |
chr4:8357970-8357971 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs554178589 |
chr4:8358007-8358008 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs572446433 |
chr4:8358013-8358014 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs543061368 |
chr4:8358043-8358044 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs555111958 |
chr4:8358048-8358049 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs573851394 |
chr4:8358055-8358056 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs544446408 |
chr4:8358098-8358099 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs562756337 |
chr4:8358103-8358104 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs144530800 |
chr4:8358144-8358145 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs184430631 |
chr4:8358148-8358149 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs560045601 |
chr4:8358155-8358156 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs7657076 |
chr4:8358192-8358193 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
16 |
rs146600045 |
chr4:8358198-8358199 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs567045141 |
chr4:8358234-8358235 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs531769915 |
chr4:8358260-8358261 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs186901766 |
chr4:8358264-8358265 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs75014689 |
chr4:8358271-8358272 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs114709672 |
chr4:8358279-8358280 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs76890796 |
chr4:8358290-8358291 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs73085853 |
chr4:8358309-8358310 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
24 |
rs536267727 |
chr4:8358334-8358335 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs547059630 |
chr4:8358349-8358350 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs3733532 |
chr4:8358361-8358362 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs28538757 |
chr4:8358381-8358382 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs28455691 |
chr4:8358383-8358384 |
Bivalent Enhancer Enhancers Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs28578263 |
chr4:8358416-8358417 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs576643915 |
chr4:8358419-8358420 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs28407751 |
chr4:8358421-8358422 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
32 |
rs28689793 |
chr4:8358430-8358431 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs535893778 |
chr4:8358436-8358437 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs28449199 |
chr4:8358437-8358438 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs554872478 |
chr4:8358469-8358470 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs143073876 |
chr4:8358497-8358498 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs569977122 |
chr4:8358509-8358510 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs577762527 |
chr4:8358523-8358524 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs545245923 |
chr4:8358528-8358529 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs537198075 |
chr4:8358533-8358534 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs558836870 |
chr4:8358568-8358569 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs183665857 |
chr4:8358575-8358576 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs188761910 |
chr4:8358582-8358583 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs560200249 |
chr4:8358613-8358614 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs189468403 |
chr4:8358614-8358615 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs545518169 |
chr4:8358634-8358635 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs79807394 |
chr4:8358661-8358662 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs78005336 |
chr4:8358666-8358667 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs201636931 |
chr4:8358673-8358674 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs77506128 |
chr4:8358696-8358697 |
Bivalent Enhancer Enhancers Bivalent/Poised TSS Weak transcription
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|